|
Please use the submission forms below for inquiries concerning investor relations.
Answers to the most frequently asked questions are also provided in the FAQ section of this Web site.
| Note: |
Personal identifiable information, such as your name, address,
phone number and e-mail address, provided via the
submission forms below is used solely for the following purposes:
1. To answer inquiries
2. To send requested investor relations materials
|
Inquiry Submission Forms
IR Materials Request
Other Inquiries
Investor Relations Contact:
Corporate Communications Group
Santen Pharmaceutical Co., Ltd.
TEL: +81-6-6321-7007
FAX: +81-6-6321-8400
E-mail: ir@santen.co.jp
Back to top
|
